News

(Reuters) -Exxon Mobil has lost its arbitration challenge to block Chevron's $55 billion Hess acquisition deal, but the top U ...
Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on Merck & Co.
When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...
The founder of Figure is moving to recombine the company he split into two parts just a year ago ...
New York Democratic mayoral nominee Zohran Mamdani faces criticism from Donald Trump, Eric Adams and others who have labeled ...
British engineer Senior Plc will sell its Aerostructures business to private equity investor Sullivan Street Partners for up ...
Jefferies has added five new stocks to its EMEA Franchise Picks list, selecting Assa Abloy (ST: ASSAb), British American ...
U.S. stock futures pointed higher Friday morning after the TSX Composite and S&P 500 benchmarks both closed at record highs ...
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
CNBC’s Dan Nathan, who is also the principal of RiskReversal Advisors, talked about a downgrade from Jefferies on Apple Inc ...
Fintel reports that on July 18, 2025, Jefferies downgraded their outlook for Mesoblast Limited - Depositary Receipt () (NasdaqGS:MESO) from Buy to Hold. Analyst Price Forecast Suggests 3.07% Downside ...
Fintel reports that on July 18, 2025, Jefferies downgraded their outlook for Clarivate (NYSE:CLVT) from Buy to Hold. Analyst ...